Annual D&A:
$1.06B-$88.97M(-7.72%)Summary
- As of today, TEVA annual D&A is $1.06 billion, with the most recent change of -$88.97 million (-7.72%) on December 31, 2024.
- During the last 3 years, TEVA annual D&A has fallen by -$265.97 million (-20.00%).
- TEVA annual D&A is now -50.01% below its all-time high of $2.13 billion, reached on December 31, 2017.
Performance
TEVA Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$249.44M-$4.46M(-1.76%)Summary
- As of today, TEVA quarterly D&A is $249.44 million, with the most recent change of -$4.46 million (-1.76%) on September 30, 2025.
- Over the past year, TEVA quarterly D&A has dropped by -$9.56 million (-3.69%).
- TEVA quarterly D&A is now -57.28% below its all-time high of $583.93 million, reached on June 30, 2017.
Performance
TEVA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$1.02B-$9.56M(-0.93%)Summary
- As of today, TEVA TTM D&A is $1.02 billion, with the most recent change of -$9.56 million (-0.93%) on September 30, 2025.
- Over the past year, TEVA TTM D&A has dropped by -$39.67 million (-3.76%).
- TEVA TTM D&A is now -52.69% below its all-time high of $2.15 billion, reached on March 31, 2018.
Performance
TEVA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TEVA Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -7.7% | -3.7% | -3.8% |
| 3Y3 Years | -20.0% | -22.3% | -23.1% |
| 5Y5 Years | -38.2% | -34.5% | -35.6% |
TEVA Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -20.0% | at low | -22.3% | +2.2% | -23.1% | at low |
| 5Y | 5-Year | -38.2% | at low | -36.9% | +2.2% | -35.6% | at low |
| All-Time | All-Time | -50.0% | +7610.3% | -57.3% | +549.4% | -52.7% | >+9999.0% |
TEVA Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $249.44M(-1.8%) | $1.02B(-0.9%) |
| Jun 2025 | - | $253.89M(+4.1%) | $1.03B(-0.5%) |
| Mar 2025 | - | $244.00M(-9.3%) | $1.03B(-2.6%) |
| Dec 2024 | $1.06B(-7.7%) | $269.00M(+3.9%) | $1.06B(+0.3%) |
| Sep 2024 | - | $259.00M(0.0%) | $1.06B(-1.8%) |
| Jun 2024 | - | $259.00M(-4.8%) | $1.08B(-3.4%) |
| Mar 2024 | - | $272.00M(+2.3%) | $1.11B(-2.6%) |
| Dec 2023 | $1.15B(-11.5%) | $266.00M(-4.3%) | $1.14B(-3.0%) |
| Sep 2023 | - | $278.10M(-6.3%) | $1.18B(-3.5%) |
| Jun 2023 | - | $296.75M(-1.5%) | $1.22B(-4.8%) |
| Mar 2023 | - | $301.15M(+0.1%) | $1.28B(-1.7%) |
| Dec 2022 | $1.30B(-2.0%) | $300.88M(-6.3%) | $1.30B(-1.4%) |
| Sep 2022 | - | $321.00M(-10.3%) | $1.32B(-0.6%) |
| Jun 2022 | - | $358.00M(+10.8%) | $1.33B(+4.2%) |
| Mar 2022 | - | $323.00M(+0.9%) | $1.28B(-4.0%) |
| Dec 2021 | $1.33B(-14.6%) | $320.00M(-2.7%) | $1.33B(-5.3%) |
| Sep 2021 | - | $329.00M(+7.9%) | $1.41B(-3.6%) |
| Jun 2021 | - | $305.00M(-18.9%) | $1.46B(-5.0%) |
| Mar 2021 | - | $376.00M(-4.8%) | $1.53B(-1.5%) |
| Dec 2020 | $1.56B(-9.6%) | $395.00M(+3.7%) | $1.56B(-1.3%) |
| Sep 2020 | - | $381.00M(-0.3%) | $1.58B(-2.5%) |
| Jun 2020 | - | $382.00M(-4.3%) | $1.62B(-4.0%) |
| Mar 2020 | - | $399.00M(-4.1%) | $1.69B(-2.6%) |
| Dec 2019 | $1.72B(-6.2%) | $416.00M(-1.3%) | $1.73B(+2.4%) |
| Sep 2019 | - | $421.64M(-6.2%) | $1.69B(-3.0%) |
| Jun 2019 | - | $449.51M(+1.1%) | $1.74B(-1.5%) |
| Mar 2019 | - | $444.76M(+18.3%) | $1.77B(-3.4%) |
| Dec 2018 | $1.84B(-13.7%) | $376.01M(-20.7%) | $1.83B(-7.4%) |
| Sep 2018 | - | $474.00M(-0.3%) | $1.98B(-3.1%) |
| Jun 2018 | - | $475.55M(-6.1%) | $2.04B(-5.0%) |
| Mar 2018 | - | $506.53M(-2.9%) | $2.15B(+0.9%) |
| Dec 2017 | $2.13B(+39.2%) | $521.76M(-2.7%) | $2.13B(+9.8%) |
| Sep 2017 | - | $536.22M(-8.2%) | $1.94B(-2.1%) |
| Jun 2017 | - | $583.93M(+20.0%) | $1.98B(+16.1%) |
| Mar 2017 | - | $486.49M(+46.5%) | $1.71B(+11.9%) |
| Dec 2016 | $1.53B(+16.9%) | $332.00M(-42.5%) | $1.52B(-0.2%) |
| Sep 2016 | - | $577.00M(+86.1%) | $1.53B(+20.7%) |
| Jun 2016 | - | $310.00M(+1.6%) | $1.26B(-1.0%) |
| Mar 2016 | - | $305.00M(-9.0%) | $1.28B(-2.3%) |
| Dec 2015 | $1.31B(-13.3%) | $335.00M(+6.3%) | $1.31B(-2.5%) |
| Sep 2015 | - | $315.00M(-2.5%) | $1.34B(-3.3%) |
| Jun 2015 | - | $323.00M(-3.6%) | $1.39B(-3.5%) |
| Mar 2015 | - | $335.00M(-9.2%) | $1.44B(-4.6%) |
| Dec 2014 | $1.51B(-8.1%) | $369.00M(+2.2%) | $1.51B(-3.4%) |
| Sep 2014 | - | $361.00M(-3.5%) | $1.56B(-2.9%) |
| Jun 2014 | - | $374.00M(-7.4%) | $1.61B(-2.4%) |
| Mar 2014 | - | $404.00M(-4.3%) | $1.65B(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $1.64B(-3.5%) | $422.05M(+3.6%) | $1.64B(+1.6%) |
| Sep 2013 | - | $407.41M(-1.4%) | $1.62B(-0.8%) |
| Jun 2013 | - | $413.05M(+3.5%) | $1.63B(+1.5%) |
| Mar 2013 | - | $398.91M(+0.6%) | $1.60B(-5.7%) |
| Dec 2012 | $1.70B(+60.1%) | $396.47M(-5.6%) | $1.70B(+4.2%) |
| Sep 2012 | - | $420.11M(+8.0%) | $1.63B(+12.5%) |
| Jun 2012 | - | $388.83M(-21.7%) | $1.45B(+12.7%) |
| Mar 2012 | - | $496.31M(+51.6%) | $1.29B(+21.1%) |
| Dec 2011 | $1.06B(+9.0%) | $327.29M(+37.4%) | $1.06B(+7.8%) |
| Sep 2011 | - | $238.24M(+5.6%) | $985.76M(-1.7%) |
| Jun 2011 | - | $225.52M(-17.1%) | $1.00B(-1.0%) |
| Mar 2011 | - | $271.88M(+8.7%) | $1.01B(+3.8%) |
| Dec 2010 | $975.36M(+7.6%) | $250.12M(-2.0%) | $975.36M(-0.1%) |
| Sep 2010 | - | $255.27M(+8.5%) | $976.78M(+1.6%) |
| Jun 2010 | - | $235.16M(+0.1%) | $961.22M(-2.0%) |
| Mar 2010 | - | $234.81M(-6.7%) | $980.50M(+8.3%) |
| Dec 2009 | $906.23M(+84.3%) | $251.54M(+4.9%) | $905.66M(+38.5%) |
| Sep 2009 | - | $239.70M(-5.8%) | $654.11M(+57.8%) |
| Jun 2009 | - | $254.45M(+59.1%) | $414.41M(+48.6%) |
| Mar 2009 | - | $159.96M(+34.5%) | $278.90M(-39.9%) |
| Dec 2008 | $491.78M(+0.2%) | - | - |
| Jun 2008 | - | $118.94M(-5.0%) | $463.74M(-3.4%) |
| Mar 2008 | - | $125.20M(+14.3%) | $479.90M(-2.4%) |
| Dec 2007 | $491.01M(+14.5%) | $109.53M(-0.5%) | $491.49M(+1.1%) |
| Sep 2007 | - | $110.07M(-18.5%) | $485.96M(-0.0%) |
| Jun 2007 | - | $135.11M(-1.2%) | $485.99M(+1.1%) |
| Mar 2007 | - | $136.78M(+31.5%) | $480.78M(+11.6%) |
| Dec 2006 | $428.86M(+76.5%) | $104.00M(-5.5%) | $431.00M(-24.4%) |
| Sep 2006 | - | $110.10M(-15.2%) | $570.00M(+23.9%) |
| Jun 2006 | - | $129.90M(+49.3%) | $459.90M(+67.5%) |
| Mar 2006 | - | $87.00M(-64.2%) | $274.50M(+13.0%) |
| Dec 2005 | $243.02M(+10.2%) | $243.00M(+537.8%) | $243.00M(>+9900.0%) |
| Jun 2005 | - | -$55.50M(-200.0%) | $0.00(-100.0%) |
| Mar 2005 | - | $55.50M | $55.50M |
| Dec 2004 | $220.51M(+73.6%) | - | - |
| Dec 2003 | $126.99M(+30.9%) | - | - |
| Dec 2002 | $96.98M(-11.1%) | - | - |
| Dec 2001 | $109.13M(+14.9%) | - | - |
| Dec 2000 | $94.98M(-66.6%) | - | - |
| Dec 1999 | $284.12M(+27.4%) | - | - |
| Dec 1998 | $222.98M(+327.8%) | - | - |
| Dec 1997 | $52.12M(+19.0%) | - | - |
| Dec 1996 | $43.80M(+65.1%) | - | - |
| Dec 1995 | $26.53M(+12.8%) | - | - |
| Dec 1994 | $23.51M(+13.6%) | - | - |
| Dec 1993 | $20.69M(+1.6%) | - | - |
| Dec 1992 | $20.37M(+47.6%) | - | - |
| Dec 1991 | $13.80M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual D&A?
- What is the all-time high annual D&A for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual D&A year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly D&A?
- What is the all-time high quarterly D&A for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly D&A year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM D&A?
- What is the all-time high TTM D&A for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM D&A year-on-year change?
What is Teva Pharmaceutical Industries Limited annual D&A?
The current annual D&A of TEVA is $1.06B
What is the all-time high annual D&A for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual D&A is $2.13B
What is Teva Pharmaceutical Industries Limited annual D&A year-on-year change?
Over the past year, TEVA annual D&A has changed by -$88.97M (-7.72%)
What is Teva Pharmaceutical Industries Limited quarterly D&A?
The current quarterly D&A of TEVA is $249.44M
What is the all-time high quarterly D&A for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly D&A is $583.93M
What is Teva Pharmaceutical Industries Limited quarterly D&A year-on-year change?
Over the past year, TEVA quarterly D&A has changed by -$9.56M (-3.69%)
What is Teva Pharmaceutical Industries Limited TTM D&A?
The current TTM D&A of TEVA is $1.02B
What is the all-time high TTM D&A for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM D&A is $2.15B
What is Teva Pharmaceutical Industries Limited TTM D&A year-on-year change?
Over the past year, TEVA TTM D&A has changed by -$39.67M (-3.76%)